A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission.
Hsu JL, Bryant CE, Papadimitrious MS, Kong B, Gasiorowski RE, Orellana D, McGuire HM, Groth BFS, Joshua DE, Ho PJ, Larsen S, Iland HJ, Gibson J, Clark GJ, Fromm PD, Hart DN.
Hsu JL, et al. Among authors: joshua de.
Oncoimmunology. 2018 Jan 25;7(4):e1419114. doi: 10.1080/2162402X.2017.1419114. eCollection 2018.
Oncoimmunology. 2018.
PMID: 29632738
Free PMC article.